Ab&B Bio-Tech (2627) Announces Independent Director Resignation and Nominates Successor

Bulletin Express
2025/12/04

Ab&B Bio-Tech CO., LTD. JS (Stock Code: 2627) has announced the resignation of Independent Non-Executive Director Ms. Li Xiaoqing. She will also step down as chairperson of the Audit Committee and as a member of both the Remuneration and Appraisal Committee and the Nomination Committee, citing personal endeavors. Her resignation takes effect once a new independent non-executive director is elected at the company’s second extraordinary general meeting of 2025.

The board has nominated Mr. Li Jianjun as a candidate for independent non-executive director of the second session of the board, pending approval at the same EGM. Mr. Li, aged 57, has over three decades of experience in accounting and tax services, having served in various tax-bureau, accounting, and audit roles. He holds an MBA from the Tsinghua University–Bangor University joint program and from China Europe International Business School, and is both a Certified Tax Advisor and a Certified Public Accountant in the People’s Republic of China.

With Mr. Li’s nomination, he will become chairperson of the Audit Committee and a member of the Remuneration and Appraisal Committee upon formal appointment. Additional board committee changes will take effect on the date he assumes the role of independent non-executive director, including updates to the membership of the Nomination Committee.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10